August 27, 2019
The U.S. Food and Drug Administration and China’s National Medical Products Administration (NMPA) have approved Euclid Systems‘ plan to manufacture the Euclid Emerald™ line of contact lenses in a new facility in Sterling, Virginia. The new space will be more than triple the size of the company’s current facility. Construction has begun but the company hasn’t announced a date for the move.
“With this new, state-of-the art facility, Euclid has the space it needs to grow as we serve the rapidly expanding orthokeratology market, providing improved vision and quality of life to kids around the world,” said Michael Ross, the company’s chairman and CEO, in a statement.
Euclid also plans to transition to a custom automated platform for manufacturing, which will help the company better serve its customer base around the world.
“The approval of our Sterling manufacturing facility comes at a critical time of increasing awareness of myopia as a global epidemic, global demand and increased interest on the quality and safety of Euclid’s products,” said Sandra Gilbert, vice president, global quality and regulatory compliance, Euclid Systems Corporation.
